Where can I buy shares of BWAY?
Shares of BWAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is Bway a packaging company?
BWAY Corporation provides packaging solutions. The Company offers plastic and metal containers, drums, cans, bottles, pails, reconditioned packaging products. BWAY serves beverages, food, aerosol, paint, personal care and pharmaceuticals, automotive, consumer, and health care industries worldwide. NO.
What are the price targets for Brainsway's shares?
5 equities research analysts have issued twelve-month price objectives for BrainsWay's shares. Their forecasts range from $12.00 to $17.00. On average, they anticipate BrainsWay's share price to reach $14.80 in the next twelve months. This suggests a possible upside of 101.4% from the stock's current price.
Should you buy Brainsway stock?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" BrainsWay stock. View analyst ratings for BrainsWay or view top-rated stocks.
Should I buy or sell BrainsWay stock right now?
3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last year. There are currently 3 buy ratings for...
What is BrainsWay's stock price forecast for 2022?
3 brokerages have issued 1 year target prices for BrainsWay's stock. Their forecasts range from $15.00 to $17.00. On average, they anticipate Brain...
How has BrainsWay's stock price performed in 2022?
BrainsWay's stock was trading at $7.70 at the beginning of 2022. Since then, BWAY stock has decreased by 17.0% and is now trading at $6.39. View t...
When is BrainsWay's next earnings date?
BrainsWay is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for BrainsWay .
How were BrainsWay's earnings last quarter?
BrainsWay Ltd. (NASDAQ:BWAY) announced its earnings results on Wednesday, November, 17th. The company reported ($0.05) earnings per share for the q...
Who are BrainsWay's key executives?
BrainsWay's management team includes the following people: Dr. Christopher R. von Jako Ph.D. , Pres & CEO (Age 53, Pay $691.96k) Mr. Richard Sco...
Who are some of BrainsWay's key competitors?
Some companies that are related to BrainsWay include IRadimed (IRMD) , MiMedx Group (MDXG) , Inovio Pharmaceuticals (INO) , Nyxoah (NYXH) , An...
What other stocks do shareholders of BrainsWay own?
Based on aggregate information from My MarketBeat watchlists, some companies that other BrainsWay investors own include AbbVie (ABBV) , Advanced...
When did BrainsWay IPO?
(BWAY) raised $30 million in an initial public offering on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Can...
About BrainsWay
BrainsWay (NASDAQ:BWAY) Frequently Asked Questions
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD).
Premium Research for BWAY
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BrainsWay in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BrainsWay stock. View analyst ratings for BrainsWay or view top-rated stocks.
Company Summary
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
